These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34239695)

  • 61. Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.
    Fonseca V; Rosenstock J; Patwardhan R; Salzman A
    JAMA; 2000 Apr; 283(13):1695-702. PubMed ID: 10755495
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serum Vitamin D Affected Type 2 Diabetes though Altering Lipid Profile and Modified the Effects of Testosterone on Diabetes Status.
    Wang L; Liu X; Hou J; Wei D; Liu P; Fan K; Zhang L; Nie L; Li X; Huo W; Jing T; Li W; Wang C; Mao Z
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33396618
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Synergistic actions of vitamin D and metformin on skeletal muscles and insulin resistance of type 2 diabetic rats.
    Amin SN; Hussein UK; Yassa HD; Hassan SS; Rashed LA
    J Cell Physiol; 2018 Aug; 233(8):5768-5779. PubMed ID: 29205344
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effects of rutin flavonoid supplement on glycemic status, lipid profile, atherogenic index of plasma, brain-derived neurotrophic factor (BDNF), some serum inflammatory, and oxidative stress factors in patients with type 2 diabetes mellitus: A double-blind, placebo-controlled trial.
    Bazyar H; Moradi L; Zaman F; Zare Javid A
    Phytother Res; 2023 Jan; 37(1):271-284. PubMed ID: 36101997
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Serum vitamin d status and its relationship to metabolic parameters in patients with type 2 diabetes mellitus.
    Yu JR; Lee SA; Lee JG; Seong GM; Ko SJ; Koh G; Kong MH; Park KY; Kim BJ; Lim DM; Lee DH
    Chonnam Med J; 2012 Aug; 48(2):108-15. PubMed ID: 22977752
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Vitamin D Deficient Older Adults Are More Prone to Have Metabolic Syndrome, but Not to a Greater Number of Metabolic Syndrome Parameters.
    Pott-Junior H; Nascimento CMC; Costa-Guarisco LP; Gomes GAO; Gramani-Say K; Orlandi FS; Gratão ACM; Orlandi AADS; Pavarini SCI; Vasilceac FA; Zazzetta MS; Cominetti MR
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32178228
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vitamin D diminishes the high platelet aggregation of type 2 diabetes mellitus patients.
    Sultan M; Twito O; Tohami T; Ramati E; Neumark E; Rashid G
    Platelets; 2019; 30(1):120-125. PubMed ID: 29313404
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
    Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
    Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of 25-hydroxyvitamin D on Helicobacter pylori eradication in patients with type 2 diabetes.
    Huang B; Yan S; Chen C; Ye S
    Wien Klin Wochenschr; 2019 Feb; 131(3-4):75-80. PubMed ID: 30542778
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serine racemase rs391300 G/A polymorphism influences the therapeutic efficacy of metformin in Chinese patients with diabetes mellitus type 2.
    Dong M; Gong ZC; Dai XP; Lei GH; Lu HB; Fan L; Qu J; Zhou HH; Liu ZQ
    Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):824-9. PubMed ID: 21933224
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Vitamin D supplementation as an adjuvant therapy for patients with T2DM: an 18-month prospective interventional study.
    Al-Daghri NM; Alkharfy KM; Al-Othman A; El-Kholie E; Moharram O; Alokail MS; Al-Saleh Y; Sabico S; Kumar S; Chrousos GP
    Cardiovasc Diabetol; 2012 Jul; 11():85. PubMed ID: 22809461
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea.
    Goldstein BJ; Pans M; Rubin CJ
    Clin Ther; 2003 Mar; 25(3):890-903. PubMed ID: 12852706
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term treatment with metformin in type 2 diabetes and vitamin D levels: A post-hoc analysis of a randomized placebo-controlled trial.
    Out M; Top WMC; Lehert P; Schalkwijk CA; Stehouwer CDA; Kooy A
    Diabetes Obes Metab; 2018 Aug; 20(8):1951-1956. PubMed ID: 29667290
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of ramadan fasting on glycemic control and other essential variables in diabetic patients.
    Bener A; A Al-Hamaq AOA; Öztürk M; Çatan F; Haris PI; Rajput KU; Ömer A
    Ann Afr Med; 2018; 17(4):196-202. PubMed ID: 30588933
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vitamin D3 as adjuvant in the treatment of type 2 diabetes mellitus: modulation of genomic and biochemical instability.
    Fagundes GE; Macan TP; Rohr P; Damiani AP; Da Rocha FR; Pereira M; Longaretti LM; Vilela TC; Ceretta LB; Mendes C; Silveira PCL; Teixeira JPF; de Andrade VM
    Mutagenesis; 2019 May; 34(2):135-145. PubMed ID: 30726950
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sleeping disturbances and predictor risk factors among type 2 diabetic mellitus patients.
    Bener A; Al-Hamaq AOAA; Agan AF; Öztürk M; Ömer A
    Ann Afr Med; 2020; 19(4):230-236. PubMed ID: 33243945
    [TBL] [Abstract][Full Text] [Related]  

  • 77. THE ASSOCIATIONS BETWEEN HYPOVITAMINOSIS D, HIGHER PTH LEVELS WITH BONE MINERAL DENSITIES, AND RISK OF THE 10-YEAR PROBABILITY OF MAJOR OSTEOPOROTIC FRACTURES IN CHINESE PATIENTS WITH T2DM.
    Wang XF; Yu JJ; Wang XJ; Jing YX; Sun LH; Tao B; Wang WQ; Ning G; Liu JM; Zhao HY
    Endocr Pract; 2018 Apr; 24(4):334-341. PubMed ID: 29658832
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High Prevalence of Vitamin D Deficiency and Correlation of Serum Vitamin D with Cardiovascular Risk in Patients with Metabolic Syndrome.
    Alkhatatbeh MJ; Abdul-Razzak KK; Khasawneh LQ; Saadeh NA
    Metab Syndr Relat Disord; 2017 Jun; 15(5):213-219. PubMed ID: 28346853
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serum 25-Hydroxyvitamin D Levels in Type 2 Diabetes Patients in North China: Seasonality and the Association between Vitamin D Status and Glycosylated Hemoglobin Levels.
    Wang C; Li H; Huo L; Wang Q; Zhang T; He X; Hao J; Luo Y; Ren L
    Int J Clin Pract; 2023; 2023():4151224. PubMed ID: 37188155
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial.
    Schernthaner G; Matthews DR; Charbonnel B; Hanefeld M; Brunetti P;
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6068-76. PubMed ID: 15579760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.